Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06351579 · ClinicalTrials.gov registry record
Data Collection Post Radical Prostatectomy
A clinical trial, sponsored by Levee Medical.
- Completed
- Registry status
- 30
- Enrollment target
NCT06351579: Completed study, sponsored by Levee Medical.
NCT06351579 is a clinical trial that has completed, run by Levee Medical. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06351579 has completed, sponsored by Levee Medical.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The study is designed to collect information on patients undergoing radical prostatectomy (RP), with a primary focus on the occurrence, duration, and severity of post-prostatectomy incontinence. Data will be collected at multiple time points, allowing for a dynamic understanding of urinary incontinence patterns at post RP.
Primary Outcome
The 24-hour (at-home) pad weight test - The pads are pre-weighed prior to providing them to subjects. The test should be started with an empty bladder. The subject will wear pads and perform their normal daily activities for 24 hours. The subject will be asked to change the pads approximately once every 6 hours during waking hours, or more frequently as needed. The pads will be stored in an air tight bag or container after removal, stored in a refrigerator, and brought to the site at the require
Interventions
- OTHER Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-03-30 |
| Est. Completion | 2025-07-30 |
What the finished NCT06351579 record still lists
NCT06351579 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Control is the first listed.
NCT06351579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06351579 about?
NCT06351579 is a clinical study titled "Data Collection Post Radical Prostatectomy". The study is designed to collect information on patients undergoing radical prostatectomy (RP), with a primary focus on the occurrence, duration, and severity of post-prostatectomy incontinence. Data will be collected at multiple time points, allowing for a dynamic understanding of urinary incontine...
What is the current status of trial NCT06351579?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2023-03-30. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT06351579?
The interventions under investigation include: Control (OTHER).
Who is sponsoring clinical trial NCT06351579?
This trial is sponsored by Levee Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI